Cargando…

Safety and efficacy of rhBMP2 in posterior cervical spinal fusion for subaxial degenerative spine disease: Analysis of outcomes in 204 patients

BACKGROUND: Many studies offer excellent demonstration of the ability of bone morphogenic protein (BMP) to enhance fusion rates in anterior as well as posterior lumbar surgery. Recently, BMP has also been shown to increase arthrodesis rates in anterior cervical surgery, albeit with concomitant incre...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Risheng, Bydon, Mohamad, Sciubba, Daniel M., Witham, Timothy F., Wolinsky, Jean-Paul, Gokaslan, Ziya L., Bydon, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications Pvt Ltd 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162798/
https://www.ncbi.nlm.nih.gov/pubmed/21886882
http://dx.doi.org/10.4103/2152-7806.83726
_version_ 1782210872610914304
author Xu, Risheng
Bydon, Mohamad
Sciubba, Daniel M.
Witham, Timothy F.
Wolinsky, Jean-Paul
Gokaslan, Ziya L.
Bydon, Ali
author_facet Xu, Risheng
Bydon, Mohamad
Sciubba, Daniel M.
Witham, Timothy F.
Wolinsky, Jean-Paul
Gokaslan, Ziya L.
Bydon, Ali
author_sort Xu, Risheng
collection PubMed
description BACKGROUND: Many studies offer excellent demonstration of the ability of bone morphogenic protein (BMP) to enhance fusion rates in anterior as well as posterior lumbar surgery. Recently, BMP has also been shown to increase arthrodesis rates in anterior cervical surgery, albeit with concomitant increases in complication rates. To date, however, few studies have investigated the safety and efficacy of BMP in cervical surgeries approached posteriorly. METHODS: We retrospectively reviewed 204 consecutive patients with degenerative cervical spinal conditions necessitating posterior cervical fusion at a single institution over the past 4 years. The incidence of postoperative mechanical neck pain, fusion rates, as well as neurologic outcomes were compared between patients who received BMP vs those who did not receive BMP intraoperatively. RESULTS: There were no significant differences in preoperative variables between the non-BMP vs the BMP cohorts. Over an average follow-up of 24.2 months, there were no significant differences between the two cohorts in duration of hospitalization, cerebrospinal fluid leakage, deep vein thrombosis, pulmonary embolism, hyperostosis, infection, pneumonia, hematoma, C5 palsy, wound dehiscence, reoperation rates, or Nurick/ASIA scores. Eleven (7.1%) patients in the non-BMP group experienced instrumentation failure vs none in the BMP group (P=0.06). Patients receiving BMP had a significantly increased rate of fusion by the chi-square test (P=0.01) and the log-rank test (P=0.02). However, patients receiving BMP also had the highest rates of recurrent/persistent neck pain by the chi-square test (P=0.003) and the log-rank test (P=0.01). CONCLUSIONS: To date, few studies have evaluated the safety and efficacy of BMP in the posterior cervical spine. Here, we show that BMP usage does not increase complication rates, but it significantly increases arthrodesis rates and also may increase the rate of recurrent/persistent neck pain.
format Online
Article
Text
id pubmed-3162798
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-31627982011-08-31 Safety and efficacy of rhBMP2 in posterior cervical spinal fusion for subaxial degenerative spine disease: Analysis of outcomes in 204 patients Xu, Risheng Bydon, Mohamad Sciubba, Daniel M. Witham, Timothy F. Wolinsky, Jean-Paul Gokaslan, Ziya L. Bydon, Ali Surg Neurol Int Original Article BACKGROUND: Many studies offer excellent demonstration of the ability of bone morphogenic protein (BMP) to enhance fusion rates in anterior as well as posterior lumbar surgery. Recently, BMP has also been shown to increase arthrodesis rates in anterior cervical surgery, albeit with concomitant increases in complication rates. To date, however, few studies have investigated the safety and efficacy of BMP in cervical surgeries approached posteriorly. METHODS: We retrospectively reviewed 204 consecutive patients with degenerative cervical spinal conditions necessitating posterior cervical fusion at a single institution over the past 4 years. The incidence of postoperative mechanical neck pain, fusion rates, as well as neurologic outcomes were compared between patients who received BMP vs those who did not receive BMP intraoperatively. RESULTS: There were no significant differences in preoperative variables between the non-BMP vs the BMP cohorts. Over an average follow-up of 24.2 months, there were no significant differences between the two cohorts in duration of hospitalization, cerebrospinal fluid leakage, deep vein thrombosis, pulmonary embolism, hyperostosis, infection, pneumonia, hematoma, C5 palsy, wound dehiscence, reoperation rates, or Nurick/ASIA scores. Eleven (7.1%) patients in the non-BMP group experienced instrumentation failure vs none in the BMP group (P=0.06). Patients receiving BMP had a significantly increased rate of fusion by the chi-square test (P=0.01) and the log-rank test (P=0.02). However, patients receiving BMP also had the highest rates of recurrent/persistent neck pain by the chi-square test (P=0.003) and the log-rank test (P=0.01). CONCLUSIONS: To date, few studies have evaluated the safety and efficacy of BMP in the posterior cervical spine. Here, we show that BMP usage does not increase complication rates, but it significantly increases arthrodesis rates and also may increase the rate of recurrent/persistent neck pain. Medknow Publications Pvt Ltd 2011-08-13 /pmc/articles/PMC3162798/ /pubmed/21886882 http://dx.doi.org/10.4103/2152-7806.83726 Text en Copyright: © 2011 Xu R. http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Original Article
Xu, Risheng
Bydon, Mohamad
Sciubba, Daniel M.
Witham, Timothy F.
Wolinsky, Jean-Paul
Gokaslan, Ziya L.
Bydon, Ali
Safety and efficacy of rhBMP2 in posterior cervical spinal fusion for subaxial degenerative spine disease: Analysis of outcomes in 204 patients
title Safety and efficacy of rhBMP2 in posterior cervical spinal fusion for subaxial degenerative spine disease: Analysis of outcomes in 204 patients
title_full Safety and efficacy of rhBMP2 in posterior cervical spinal fusion for subaxial degenerative spine disease: Analysis of outcomes in 204 patients
title_fullStr Safety and efficacy of rhBMP2 in posterior cervical spinal fusion for subaxial degenerative spine disease: Analysis of outcomes in 204 patients
title_full_unstemmed Safety and efficacy of rhBMP2 in posterior cervical spinal fusion for subaxial degenerative spine disease: Analysis of outcomes in 204 patients
title_short Safety and efficacy of rhBMP2 in posterior cervical spinal fusion for subaxial degenerative spine disease: Analysis of outcomes in 204 patients
title_sort safety and efficacy of rhbmp2 in posterior cervical spinal fusion for subaxial degenerative spine disease: analysis of outcomes in 204 patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162798/
https://www.ncbi.nlm.nih.gov/pubmed/21886882
http://dx.doi.org/10.4103/2152-7806.83726
work_keys_str_mv AT xurisheng safetyandefficacyofrhbmp2inposteriorcervicalspinalfusionforsubaxialdegenerativespinediseaseanalysisofoutcomesin204patients
AT bydonmohamad safetyandefficacyofrhbmp2inposteriorcervicalspinalfusionforsubaxialdegenerativespinediseaseanalysisofoutcomesin204patients
AT sciubbadanielm safetyandefficacyofrhbmp2inposteriorcervicalspinalfusionforsubaxialdegenerativespinediseaseanalysisofoutcomesin204patients
AT withamtimothyf safetyandefficacyofrhbmp2inposteriorcervicalspinalfusionforsubaxialdegenerativespinediseaseanalysisofoutcomesin204patients
AT wolinskyjeanpaul safetyandefficacyofrhbmp2inposteriorcervicalspinalfusionforsubaxialdegenerativespinediseaseanalysisofoutcomesin204patients
AT gokaslanziyal safetyandefficacyofrhbmp2inposteriorcervicalspinalfusionforsubaxialdegenerativespinediseaseanalysisofoutcomesin204patients
AT bydonali safetyandefficacyofrhbmp2inposteriorcervicalspinalfusionforsubaxialdegenerativespinediseaseanalysisofoutcomesin204patients